Rickels K
Psychopharmacology (Berl). 1978 Jun 15;58(1):1-17. doi: 10.1007/BF00426784.
The present paper reviews the role of antianxiety agents in the treatment of nonpsychotic anxious patients. Major emphasis is placed on findings from clinical trials conducted by this research group. Consideration is given to the relative efficacy of available antianxiety agents, to patients response in relation to patterns of symptomatology, and to the degree of symptom relief experienced by drug-treated anxious patients. Also discussed are some of the many nonspecific factors that affect improvement with drug treatment in general and with the benzodiazepines in particular. It is concluded that many anxious patients are not currently receiving adequate drug treatment, and may require longer periods of drug therapy or supplemental nondrug intervention.
本文综述了抗焦虑药物在治疗非精神病性焦虑患者中的作用。重点是该研究小组进行的临床试验结果。文中考虑了现有抗焦虑药物的相对疗效、患者对症状模式的反应,以及药物治疗的焦虑患者的症状缓解程度。还讨论了许多影响一般药物治疗尤其是苯二氮䓬类药物治疗效果的非特异性因素。得出的结论是,许多焦虑患者目前未得到充分的药物治疗,可能需要更长时间的药物治疗或补充非药物干预。